More people in England with persistent bad indigestion could be offered a quick “sponge in the gullet” test to check for oesophageal cancer, under new draft guidelines from the National Institute for Health and Care Excellence (NICE).
The capsule‑based test uses a dissolving capsule attached to a thread, which releases a tiny sponge in the stomach. The sponge collects cells from the lining of the gullet as it is gently pulled back out. It can be carried out in a GP surgery in minutes and is less invasive than a hospital endoscopy, which uses a small camera. The tests are already available in some areas but could now be rolled out across England.
Heartburn or acid reflux can occur with a condition called Barrett’s oesophagus, where cells in the gullet lining have started to change. It is thought that between one and two adults in every 100 have Barrett’s oesophagus, and while most will not go on to develop cancer, demand for NHS endoscopy is high, meaning some are not checked as often as recommended. NICE says the sponge tests could help give more patients peace of mind.
Prof Jonathan Benger, chief executive of NICE, said the tests offer a “quick and less invasive” way to detect concerning changes, helping to identify people who should go on to further tests and treatment.
Prof Peter Johnson, national clinical director for cancer at NHS England, said: “The NHS is always looking for better ways to get to the bottom of people's symptoms, and thousands have already benefited from this incredibly efficient test through pilots we have been running, so it's fantastic it is now being considered for roll out across the country.” He added that many people have acid reflux, and “having an easier way to check for changes in the lining of the oesophagus can make a big difference for patients, reducing the need for more complicated endoscopy tests and helping the NHS free up resources to find cancers at an earlier stage.”
NICE says no diagnostic test, including endoscopy, identifies every case, and people who receive an all‑clear sponge test result should still be monitored in the long term. The final recommendations from NICE will be made in the new year.
Analysis
Why This Matters
- The sponge test offers a faster, less invasive alternative to endoscopy for people with persistent indigestion, potentially freeing up NHS resources and reducing patient waiting times.
- Wider rollout could lead to earlier detection of oesophageal cancer or pre‑cancerous changes, improving treatment outcomes.
- The move addresses a gap in monitoring: high demand for endoscopy means some at‑risk patients are not checked as often as recommended.
Background
Oesophageal cancer often develops from Barrett’s oesophagus, a condition linked to chronic acid reflux. Symptoms include heartburn and an unpleasant sour taste. Factors such as being overweight, smoking and drinking alcohol increase reflux risk. The sponge test (also known as the “cytosponge”) has been piloted in parts of England; if adopted nationally, it would become a standard option for primary‑care screening.
Key Perspectives
- NICE: The sponge tests offer a “quick and less invasive” way to detect concerning changes and should be offered to more patients.
- NHS England: Thousands have already benefited from the test in pilots, and rollout could reduce the need for endoscopy, allowing resources to focus on earlier cancer detection.
- NICE (caveat): The test does not catch every case, so patients with a clear result still need long‑term monitoring.
What to Watch
- Final NICE recommendations, expected in the new year, will determine the scope and timeline of the rollout.
- Uptake rates among GP surgeries and patient willingness to use the sponge test compared with endoscopy.
- Any impact on endoscopy waiting lists and cancer detection rates in oesophageal cancer.
Checked
12 claims in this story checked against 1 source: 11 supported.
Show each claim
- Partly supportedThe NHS in England is considering a rollout of the sponge tests for people with bad, persistent indigestion.BBC News: “Some people with bad and persistent indigestion should be offered quick "sponge in the gullet" tests to check for oesophageal cancer, new draft guidelines for the NHS in England recommend.”
- SupportedDraft NICE guidelines recommend wider use of the tests.BBC News: “Some people with bad and persistent indigestion should be offered quick "sponge in the gullet" tests to check for oesophageal cancer, new draft guidelines for the NHS in England recommend.”
- SupportedThe draft guidelines recommend the test to detect oesophageal cancer and Barrett’s oesophagus.BBC News: “The sponge tests can help detect oesophageal cancer and Barrett's oesophagus in people with reflux disease.”
- SupportedNICE’s final recommendations are expected next year.BBC News: “Final recommendations by NICE will be made in the new year.”
- SupportedMore people in England with persistent bad indigestion could be offered the test under the draft guidelines.BBC News: “Some people with bad and persistent indigestion should be offered quick "sponge in the gullet" tests to check for oesophageal cancer, new draft guidelines for the NHS in England recommend.”
- SupportedThe capsule dissolves in the stomach and releases a sponge that collects cells from the gullet lining as it is pulled out.BBC News: “For the test, patients swallow a small dissolving capsule attached to a thread. Once in the stomach, it releases a tiny sponge. This collect cells from the lining of the gullet as it's gently pulled back out of the patient's mouth by the doctor.”
- SupportedThe test can be done in a GP surgery in minutes and is less invasive than hospital endoscopy.BBC News: “The sponge tests can be carried out in GP surgeries in minutes, and are less invasive than hospital endoscopy checks that instead use a small camera to look inside the body.”
- SupportedIt is thought that one to two adults in every 100 have Barrett’s oesophagus.BBC News: “It's thought between one and two adults in every 100 has Barrett's oesophagus, where cells have started to change.”
- SupportedProf Jonathan Benger said the tests offer a “quick and less invasive” way to detect concerning changes and help identify people for further tests and treatment.BBC News: “Prof Jonathan Benger, chief executive of NICE, says sponge tests offer a "quick and less invasive" way to detect concerning changes, helping to identify people who should go on to have further tests and treatment.”
- SupportedProf Peter Johnson said thousands had already benefited from pilots and the test was being considered for rollout across the country.BBC News: “The NHS is always looking for better ways to get to the bottom of people's symptoms, and thousands have already benefited from this incredibly efficient test through pilots we have been running, so it's fantastic it is now being considered for roll out across the country.”
- SupportedProf Peter Johnson said easier checks could reduce the need for more complicated endoscopy tests and help the NHS find cancers earlier.BBC News: “Many people have acid reflux, and having an easier way to check for changes in the lining of the oesophagus can make a big difference for patients, reducing the need for more complicated endoscopy tests and helping the NHS free up resources to find cancers at an earlier stage.”
- SupportedPeople with an all-clear sponge test result should still be monitored in the long term because no diagnostic test identifies every case.BBC News: “However, no diagnostic test, including endoscopy, identifies every case and people who receive an all-clear sponge test result should still be monitored in the long term, NICE adds.”